ICL Group grants 731,707 options to EVP CIO

ICL Group Ltd. reported a grant of stock options to its EVP, Global CIO, Alegra Kilstein.

Accepted by SEC EDGAR 08/05/2026 - 04:03 PM EDT Learn about SEC filing dates

Rhea-AI Filing Summary

ICL Group Ltd. reported a grant of stock options to its EVP, Global CIO, Alegra Kilstein. The award covers 731,707 stock options to buy Ordinary Shares at an exercise price of $5.05 (NIS 15.31) per share, vesting in three equal annual installments from August 4, 2026 and expiring on August 4, 2031. The options are held by a trustee in her name.

Insider Trade Summary

Grant/Award: 731,707 shares

Grant/Award 1 txn

Insider Kilstein Alegra

Role EVP, Global CIO

Type	Security	Shares	Price	Value
Grant/Award	Stock Options (Right to Buy) F1, F2, F3	731,707	$0.00	$0.00

Holdings After Transaction: Stock Options (Right to Buy) — 731,707 contracts (Direct)

Footnotes (3)

1. F1. Represents an exercise price of NIS 15.31, converted to U.S. dollars using the Bank of Israel representative exchange rate of $1.00 to NIS 3.0300 as of 8/4/2026.
2. F2. The stock options vest in three equal annual installments from the 8/4/2026 grant date.
3. F3. The options are held by a Trustee in the name of the Reporting Person.

Key Figures

Stock options granted: 731707.0000 options Exercise price: $5.0500 per share Exercise price in NIS: NIS 15.31 per share +4 more

7 metrics

Stock options granted 731707.0000 options Grant to EVP, Global CIO Alegra Kilstein on 8/4/2026

Exercise price $5.0500 per share Exercise price for options to buy Ordinary Shares

Exercise price in NIS NIS 15.31 per share Converted to $5.05 using $1.00 = NIS 3.0300 as of 8/4/2026

Underlying Ordinary Shares 731707.0000 shares Underlying security for the granted stock options

Expiration date 2031-08-04 Date on which the stock options expire

Vesting schedule 3 equal annual installments Options vest annually starting from the 8/4/2026 grant date

FX rate used $1.00 to NIS 3.0300 Bank of Israel representative exchange rate as of 8/4/2026

Key Terms

Stock Options (Right to Buy), exercise price, vest in three equal annual installments, Trustee

4 terms

Stock Options (Right to Buy) financial

"security_title: Stock Options (Right to Buy)"

exercise price financial

"Represents an exercise price of NIS 15.31, converted to U.S. dollars"

The exercise price is the fixed amount at which you can buy or sell an asset, like a stock, when using an options contract. It matters because it helps determine whether exercising the option will be profitable or not, depending on the current market price. Think of it as the set price you agree on today to buy or sell later.

vest in three equal annual installments financial

"The stock options vest in three equal annual installments"

Trustee financial

"The options are held by a Trustee in the name of the Reporting Person"

A trustee is a person or institution legally appointed to hold and manage assets or enforce an agreement on behalf of other people (beneficiaries). Think of a trustee as a neutral referee or custodian who must act in the beneficiaries’ best interests, follow the trust or contract rules, and handle distributions, recordkeeping and enforcement. Investors care because a trustworthy trustee protects their rights, ensures promised payments or remedies are delivered, and can influence recoveries if things go wrong.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What insider transaction did ICL (ICL) report for Alegra Kilstein?

ICL reported that EVP, Global CIO Alegra Kilstein received a grant of 731,707 stock options. These options allow her to buy Ordinary Shares at $5.05 per share, vest over three years, and expire on August 4, 2031.

What is the exercise price of the new stock options in ICL (ICL)'s filing?

The stock options granted carry an exercise price of $5.05 per share. This reflects an exercise price of NIS 15.31, converted using a Bank of Israel exchange rate of $1.00 to NIS 3.0300 as of August 4, 2026.

How do the ICL (ICL) stock options granted to Alegra Kilstein vest?

The options granted to Alegra Kilstein vest in three equal annual installments. Vesting begins from the August 4, 2026 grant date, meaning one-third of the options vest each year over a three-year period.

When do the ICL (ICL) stock options granted to Alegra Kilstein expire?

The granted stock options expire on August 4, 2031. After this expiration date, any unexercised options will lapse and can no longer be used to purchase ICL Group Ltd. Ordinary Shares under this award.

How many ICL (ICL) Ordinary Shares underlie Alegra Kilstein’s option grant?

The option grant covers 731,707 underlying Ordinary Shares. Each stock option represents the right to purchase one Ordinary Share of ICL Group Ltd., subject to the vesting schedule and the $5.05 per share exercise price.

How are the ICL (ICL) options granted to Alegra Kilstein held?

The filing states that the options are held by a Trustee in the name of the reporting person. This means legal title is with the trustee, while the economic interest and reporting obligations remain with Alegra Kilstein.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Kilstein Alegra

(Last) (First) (Middle)

C/O ICL GROUP LTD.

LANDMARK TOWER, 2 LEONARDO DA VINCI ST.

(Street)

TEL AVIV 6473913

(City) (State) (Zip)

ISRAEL

(Country)

2. Issuer Name and Ticker or Trading Symbol
ICL Group Ltd. [ ICL ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	EVP, Global CIO

2a. Foreign Trading Symbol
[ICL]

3. Date of Earliest Transaction (Month/Day/Year)
08/04/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Stock Options (Right to Buy)	$5.05(1)	08/04/2026		A		731,707		(2)	08/04/2031	Ordinary Shares	731,707	$0	731,707	D(3)

Explanation of Responses:

1. Represents an exercise price of NIS 15.31, converted to U.S. dollars using the Bank of Israel representative exchange rate of $1.00 to NIS 3.0300 as of 8/4/2026.

2. The stock options vest in three equal annual installments from the 8/4/2026 grant date.

3. The options are held by a Trustee in the name of the Reporting Person.

	/s/ Kilstein Alegra	08/05/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)